Keyword: Astellas

News

Astellas Acquires Xyphos Biosciences

09.01.2020 - Japanese drugmaker Astellas Pharma has boosted its immuno-oncology capabilities with the purchase of US-based Xyphos Biosciences. The acquisition was the second last month for the...

News

Astellas Pays $3 Billion for Audentes

10.12.2019 - Japanese drugmaker Astellas Pharma has announced plans to acquire US gene therapy company Audentes Therapeutics for around $3 billion. The boards of directors of both companies...

News

ABPI Extends Suspension of Astellas UK

28.06.2017 - The Association of the British Pharmaceutical Industry (ABPI) has suspended Astellas UK’s membership for a further 12 months from Jun. 24 because of several serious breaches of its...

News

Astellas Pays €800 Million for Ogeda

07.04.2017 - Japan’s Astellas Pharma has agreed to buy privately held Belgian drug developer Ogeda in a transaction worth up to €800 million. The acquisition expands the Tokyo-headquartered...

News

NIH Won't Cut Price of Prostate Drug

29.06.2016 - The US federal government’s National Institutes of Health (NIH) has declined a petition from a public interest group to lower the price of a drug for advanced prostate cancer...

News

FDA Warns Of Heart Risks with Astellas Stress Test Chemicals

21.11.2013 - The U.S. Food and Drug Administration warned physicians on Wednesday that two chemicals used to conduct cardiovascular stress tests can cause heart attacks and death, and it...

News

China Blocks GSK Finance Head From Leaving Country

18.07.2013 - Chinese authorities investigating the alleged bribery of doctors and officials by GlaxoSmithKline have stopped the drugmaker's head of finance for China, a British citizen, from...

News

Astellas, GSK Vie to Make 'High Altitude' Anaemia Pill

19.04.2013 - Japan's Astellas Pharma and Britain's GlaxoSmithKline are competing to develop a new kind of medicine that boosts production of red blood cells by making the body think it is at...